Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Calcified Tissue International
Published in: Calcified Tissue International 1/2013

01-01-2013 | Original Research

Fourier Transform Infrared Imaging as a Tool to Chemically and Spatially Characterize Matrix-Mineral Deposition in Osteoblasts

Authors: Meghan E. Faillace, Roger J. Phipps, Lisa M. Miller

Published in: Calcified Tissue International | Issue 1/2013

Login to get access

Abstract

Mineralizing osteoblasts are regularly used to study osteogenesis and model in vivo bone formation. Thus, it is important to verify that the mineral and matrix being formed in situ are comparable to those found in vivo. However, it has been shown that histochemical techniques alone are not sufficient for identifying calcium phosphate-containing mineral. The goal of the present study was to demonstrate the use of Fourier transform infrared imaging (FTIRI) as a tool for characterizing the spatial distribution and colocalization of the collagen matrix and the mineral phase during the mineralization process of osteoblasts in situ. MC3T3-E1 mouse osteoblasts were mineralized in culture for 28 days and FTIRI was used to evaluate the collagen content, collagen cross-linking, mineralization level and speciation, and mineral crystallinity in a spatially resolved fashion as a function of time. To test whether FTIRI could detect subtle changes in the mineralization process, cells were treated with risedronate (RIS). Results showed that collagen deposition and mineralization progressed over time and that the apatite mineral was associated with a collagenous matrix rather than ectopic mineral. The process was temporarily slowed by RIS, where the inhibition of osteoblast function caused slowed collagen production and cross-linking, leading to decreased mineralization. This study demonstrates that FTIRI is a complementary tool to histochemistry for spatially correlating the collagen matrix distribution and the nature of the resultant mineral during the process of osteoblast mineralization. It can further be used to detect small perturbations in the osteoid and mineral deposition process.
Literature
1.
World Health Organization (2003) Prevention and management of osteoporosis. Report of a WHO Scientific Group. WHO Technical Report Series 921. World Health Organization, Geneva
2.
Aronow MA, Gerstenfeld LC (1988) Culture conditions requisite for maximal expression of the osteoblast phenotype. J Bone Miner Res 3:S136
3.
Franceschi RT, Iyer BS (1992) Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J Bone Miner Res 7:235–246PubMedCrossRef
4.
Glimcher MJ, Hodge AJ, Schmitt FO (1957) Macromolecular aggregation states in relation to mineralization: the collagen–hydroxyapatite system as studied in vitro. Proc Natl Acad Sci USA 43:860–867PubMedCrossRef
5.
Sudo H, Kodama HA, Amagai Y, Yamamoto S, Kasai S (1983) In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 96:191–198PubMedCrossRef
6.
Gokhale J, Robey PG, Boskey AL (2001) The biochemistry of bone. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, San Diego
7.
Meng Y, Qin YX, Dimasi E, Ba X, Rafailovich M, Pernodet N (2009) Biomineralization of a self-assembled extracellular matrix for bone tissue engineering. Tissue Eng Part A 15:355–366PubMedCrossRef
8.
Marieb E (1998) Human anatomy and physiology. Benjamin/Cummings Science Publishing, Menlo Park, CA
9.
Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT (1999) Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res 14:893–903PubMedCrossRef
10.
Boskey AL, Roy R (2008) Cell culture systems for studies of bone and tooth mineralization. Chem Rev 108:4716–4733PubMedCrossRef
11.
Stein GS, Lian JB, Owen TA (1990) Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 4:3111–3123PubMed
12.
Ibaraki K, Termine JD, Whitson SW, Young MF (1992) Bone matrix mRNA expression in differentiating fetal bovine osteoblasts. J Bone Miner Res 7:743–754PubMedCrossRef
13.
Beck GR Jr, Zerler B, Moran E (2001) Gene array analysis of osteoblast differentiation. Cell Growth Differ 12:61–83PubMed
14.
Marsh ME, Munne AM, Vogel JJ, Cui Y, Franceschi RT (1995) Mineralization of bone-like extracellular matrix in the absence of functional osteoblasts. J Bone Miner Res 10:1635–1643PubMedCrossRef
15.
Anderson HC, Garimella R, Tague SE (2005) The role of matrix vesicles in growth plate development and biomineralization. Front Biosci 10:822–837PubMedCrossRef
16.
Anderson HC (1995) Molecular biology of matrix vesicles. Clin Orthop Relat Res 314:266–280PubMed
17.
18.
Bonewald LF, Harris SE, Rosser J, Dallas MR, Dallas SL, Camacho NP, Boyan B, Boskey A (2003) Von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation. Calc Tissue Int 72:537–547CrossRef
19.
Rey C, Renugopalakrishnan V, Collins B, Glimcher MJ (1991) Fourier transform infrared spectroscopic study of the carbonate ions in bone mineral during aging. Calc Tissue Int 49:251–258CrossRef
20.
Rey C, Shimizu M, Collins B, Glimcher MJ (1990) Resolution-enhanced Fourier transform infrared spectroscopy study of the environment of phosphate ions in the early deposits of a solid phase of calcium-phosphate in bone and enamel, and their evolution with age. I: investigations in the upsilon 4 PO4 domain. Calc Tissue Int 46:384–394CrossRef
21.
Rey C, Shimizu M, Collins B, Glimcher MJ (1991) Resolution-enhanced Fourier transform infrared spectroscopy study of the environment of phosphate ions in the early deposits of solid phase calcium phosphate in bone and enamel and their evolution with age: 2. Investigations in the ν3 PO4 domain. Calc Tissue Int 49:383–388CrossRef
22.
Boskey AL, Pleshko N, Doty SB, Mendelsohn R (1992) Applications of Fourier transform infrared (FT-IR) microscopy to the study of mineralization in bone and cartilage. Cells Mater 2:209–220
23.
Miller LM, Little W, Schirmer A, Sheik F, Busa B, Judex S (2007) Accretion of bone quantity and quality in the developing mouse skeleton. J Bone Miner Res 22:1037–1045PubMedCrossRef
24.
Busa B, Miller LM, Rubin CT, Qin YX, Judex S (2005) Rapid establishment of chemical and mechanical properties during lamellar bone formation. Calc Tissue Int 77:386–394CrossRef
25.
Paschalis EP, Betts F, DiCarlo E, Mendelsohn R, Boskey AL (1997) FTIR microspectroscopic analysis of human iliac crest biopsies from untreated osteoporotic bone. Calc Tissue Int 61:487–492CrossRef
26.
Boskey AL, DiCarlo E, Paschalis E, West P, Mendelsohn R (2005) Comparison of mineral quality and quantity in iliac crest biopsies from high- and low-turnover osteoporosis: an FT-IR microspectroscopic investigation. Osteoporos Int 16:2031–2038PubMedCrossRef
27.
Gourion-Arsiquaud S, Faibish D, Myers E, Spevak L, Compston J, Hodsman A, Shane E, Recker RR, Boskey ER, Boskey AL (2009) Use of FTIR spectroscopic imaging to identify parameters associated with fragility fracture. J Bone Miner Res 24:1565–1571PubMedCrossRef
28.
Huang RY, Miller LM, Carlson CS, Chance MR (2003) In situ chemistry of osteoporosis revealed by synchrotron infrared microspectroscopy. Bone 33:514–521PubMedCrossRef
29.
Donnelly E, Meredith DS, Nguyen JT, Gladnick BP, Rebolledo BJ, Shaffer AD, Lorich DG, Lane JM, Boskey AL (2012) Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures. J Bone Miner Res 27:672–678PubMedCrossRef
30.
Miller LM, Novatt JT, Hamerman D, Carlson CS (2004) Alterations in mineral composition observed in osteoarthritic joints of cynomolgus monkeys. Bone 35:498–506PubMedCrossRef
31.
Boskey A, Pleshko Camacho N (2007) FT-IR imaging of native and tissue-engineered bone and cartilage. Biomaterials 28:2465–2478PubMedCrossRef
32.
33.
Faibish D, Gomes A, Boivin G, Binderman I, Boskey A (2005) Infrared imaging of calcified tissue in bone biopsies from adults with osteomalacia. Bone 36:6–12PubMedCrossRef
34.
Lindahl K, Barnes AM, Fratzl-Zelman N, Whyte MP, Hefferan TE, Makareeva E, Brusel M, Yaszemski MJ, Rubin CJ, Kindmark A, Roschger P, Klaushofer K, McAlister WH, Mumm S, Leikin S, Kessler E, Boskey AL, Ljunggren O, Marini JC (2011) COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. Hum Mutat 32:598–609PubMedCrossRef
35.
Mochida Y, Parisuthiman D, Pornprasertsuk-Damrongsri S, Atsawasuwan P, Sricholpech M, Boskey AL, Yamauchi M (2009) Decorin modulates collagen matrix assembly and mineralization. Matrix Biol 28:44–52PubMedCrossRef
36.
Turecek C, Fratzl-Zelman N, Rumpler M, Buchinger B, Spitzer S, Zoehrer R, Durchschlag E, Klaushofer K, Paschalis EP, Varga F (2008) Collagen cross-linking influences osteoblastic differentiation. Calc Tissue Int 82:392–400CrossRef
37.
Lim JY, Shaughnessy MC, Zhou Z, Noh H, Vogler EA, Donahue HJ (2008) Surface energy effects on osteoblast spatial growth and mineralization. Biomaterials 29:1776–1784PubMedCrossRef
38.
Luppen CA, Leclerc N, Noh T, Barski A, Khokhar A, Boskey AL, Smith E, Frenkel B (2003) Brief bone morphogenetic protein 2 treatment of glucocorticoid-inhibited MC3T3-E1 osteoblasts rescues commitment-associated cell cycle and mineralization without alteration of Runx2. J Biol Chem 278:44995–45003PubMedCrossRef
39.
Boyan BD, Bonewald LF, Paschalis EP, Lohmann CH, Rosser J, Cochran DL, Dean DD, Schwartz Z, Boskey AL (2002) Osteoblast-mediated mineral deposition in culture is dependent on surface microtopography. Calc Tissue Int 71:519–529CrossRef
40.
Chesnick IE, Avallone FA, Leapman RD, Landis WJ, Eidelman N, Potter K (2007) Evaluation of bioreactor-cultivated bone by magnetic resonance microscopy and FTIR microspectroscopy. Bone 40:904–912PubMedCrossRef
41.
Magne D, Bluteau G, Lopez-Cazaux S, Weiss P, Pilet P, Ritchie HH, Daculsi G, Guicheux J (2004) Development of an odontoblast in vitro model to study dentin mineralization. Connect Tissue Res 45:101–108PubMedCrossRef
42.
About I, Mitsiadis TA (2001) Molecular aspects of tooth pathogenesis and repair: in vivo and in vitro models. Adv Dent Res 15:59–62PubMedCrossRef
43.
Jikko A, Aoba T, Murakami H, Takano Y, Iwamoto M, Kato Y (1993) Characterization of the mineralization process in cultures of rabbit growth plate chondrocytes. Dev Biol 156:372–380PubMedCrossRef
44.
Shukunami C, Ishizeki K, Atsumi T, Ohta Y, Suzuki F, Hiraki Y (1997) Cellular hypertrophy and calcification of embryonal carcinoma-derived chondrogenic cell line ATDC5 in vitro. J Bone Miner Res 12:1174–1188PubMedCrossRef
45.
Still K, Phipps RJ, Scutt A (2003) Effects of risedronate, alendronate, and etidronate on the viability and activity of rat bone marrow stromal cells in vitro. Calc Tissue Int 72:143–150CrossRef
46.
von Knoch F, Jaquiery C, Kowalsky M, Schaeren S, Alabre C, Martin I, Rubash HE, Shanbhag AS (2005) Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells. Biomaterials 26:6941–6949CrossRef
47.
Coxon FP, Thompson K, Roelofs AJ, Ebetino FH, Rogers MJ (2008) Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells. Bone 42:848–860PubMedCrossRef
48.
Im GI, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS (2004) Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 25:4105–4115PubMedCrossRef
49.
Subburaman K, Pernodet N, Kwak SY, DiMasi E, Ge S, Zaitsev V, Ba X, Yang NL, Rafailovich M (2006) Templated biomineralization on self-assembled protein fibers. Proc Natl Acad Sci USA 103:14672–14677PubMedCrossRef
50.
Pernodet N, Rafailovich M, Sokolov J, Xu D, Yang N-L, McLeod K (2003) Fibronectin fibrillogenesis on sulfonated polystyrene surface. J Biomed Mater Res 64A:684–692CrossRef
51.
Liu KZ, Jackson M, Sowa MG, Ju HS, Dixon IMC, Mantsch HH (1996) Modification of the extracellular matrix following myocardial infarction monitored by FTIR spectroscopy. Biochim Biophys Acta Mol Basis Dis 1315:73–77CrossRef
52.
Gough KM, Zelinski D, Wiens R, Rak M, Dixon IM (2003) Fourier transform infrared evaluation of microscopic scarring in the cardiomyopathic heart: effect of chronic AT1 suppression. Anal Biochem 316:232–242PubMedCrossRef
53.
Camacho NP, West P, Torzilli PA, Mendelsohn R (2001) FTIR microscopic imaging of collagen and proteoglycan in bovine cartilage. Biopolymers 62:1–8PubMedCrossRef
54.
Jackson M, Sowa MG, Mantsch HH (1997) Infrared spectroscopy: a new frontier in medicine. Biophys Chem 68:109–125PubMedCrossRef
55.
Paschalis EP, DiCarlo E, Betts F, Sherman P, Mendelsohn R, Boskey AL (1996) FTIR microspectroscopic analysis of human osteonal bone. Calc Tissue Int 59:480–487
56.
Lasch P, Pacifico A, Diem M (2002) Spatially resolved IR microspectroscopy of single cells. Biopolymers 67:335–338PubMedCrossRef
57.
Gadaleta SJ, Paschalis EP, Betts F, Mendelsohn R, Boskey AL (1996) Fourier transform infrared spectroscopy of the solution-mediated conversion of amorphous calcium phosphate to hydroxyapatite: new correlations between X-ray diffraction and infrared data. Calc Tissue Int 58:9–16CrossRef
58.
Arsenault AL, Frankland BW, Ottensmeyer FP (1991) Vectorial sequence of mineralization in the turkey leg tendon determined by electron microscopic imaging. Calc Tissue Int 48:46–55CrossRef
59.
Kirsch T, Wuthier RE (1994) Stimulation of calcification of growth plate cartilage matrix vesicles by binding to type II and X collagens. J Biol Chem 269:11462–11469PubMed
60.
Landis WJ, Arsenault AL (1989) Vesicle- and collagen-mediated calcification in the turkey leg tendon. Connect Tissue Res 22:35–42PubMedCrossRef
61.
Wu LN, Sauer GR, Genge BR, Wuthier RE (1989) Induction of mineral deposition by primary cultures of chicken growth plate chondrocytes in ascorbate-containing media. Evidence of an association between matrix vesicles and collagen. J Biol Chem 264:21346–21355PubMed
62.
Reszka AA, Halasy-Nagy J, Rodan GA (2001) Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation. Mol Pharmacol 59:193–202PubMed
63.
64.
Rogers MJ, Frith JC, Luckman SP, Coxon FP, Russell RG (1999) Molecular mechanisms of action of bisphosphonates. Bone 24:73S–79SPubMedCrossRef
65.
Rogers MJ (2003) New insights into the molecular mechanisms of action of bisphosphonates. Curr Pharm Des 9:2643–2658PubMedCrossRef
66.
Fleisch H (1993) Bisphosphonates in osteoporosis: an introduction. Osteoporos Int 3(suppl 3):S3–S5PubMedCrossRef
67.
Francis MD, Russell RG, Fleisch H (1969) Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Science 165:1264–1266PubMedCrossRef
68.
Iwata K, Li J, Follet H, Phipps RJ, Burr DB (2006) Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia. Bone 39:1053–1058PubMedCrossRef
69.
Ono K, Wada S (2004) Regulation of calcification by bisphosphonates. Clin Calcium 14:60–63PubMed
70.
Vitte C, Fleisch H, Guenther HL (1996) Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption. Endocrinology 137:2324–2333PubMedCrossRef
71.
Williams G, Sallis JD (1982) Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation. Calc Tissue Int 34:169–177CrossRef
72.
Idris AI, Rojas J, Greig IR, Van’t Hof RJ, Ralston SH (2008) Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro. Calc Tissue Int 82:191–201CrossRef
73.
Fromigue O, Body JJ (2002) Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts. J Endocrinol Invest 25:539–546PubMed
74.
Igarashi K, Hirafuji M, Adachi H, Shinoda H, Mitani H (1997) Effects of bisphosphonates on alkaline phosphatase activity, mineralization, and prostaglandin E2 synthesis in the clonal osteoblast-like cell line MC3T3-E1. Prostaglandins Leukot Essent Fatty Acids 56:121–125PubMedCrossRef
75.
Reinholz GG, Getz B, Pederson L, Sanders ES, Subramaniam M, Ingle JN, Spelsberg TC (2000) Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res 60:6001–6007PubMed
76.
Giuliani N, Pedrazzoni M, Negri G, Passeri G, Impicciatore M, Girasole G (1998) Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo. Bone 22:455–461PubMedCrossRef
77.
Kellinsalmi M, Monkkonen H, Monkkonen J, Leskela HV, Parikka V, Hamalainen M, Lehenkari P (2005) In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell–derived osteoblasts. Basic Clin Pharmacol Toxicol 97:382–391PubMedCrossRef
78.
Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, Mangood A, Russell RG, Ebetino FH (2006) Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone 38:617–627PubMedCrossRef
79.
Garcia-Moreno C, Serrano S, Nacher M, Farre M, Diez A, Marinoso ML, Carbonell J, Mellibovsky L, Nogues X, Ballester J, Aubia J (1998) Effect of alendronate on cultured normal human osteoblasts. Bone 22:233–239PubMedCrossRef
80.
Coxon FP, Thompson K, Ebetino FH, Rogers MJ (2005) Resorbing osteoclasts increase the availability of mineral-bound bisphosphonates to non-resorbing cells. J Bone Miner Res 20:s260
81.
Gasser J, Ingold P, Rebmann A, Susa M, Green J (2006) Resorbing osteoclasts increase the availability of mineral-bound bisphosphonates to non-resorbing cells. Bone 38:50–51CrossRef
82.
Allen MR, Follet H, Khurana M, Sato M, Burr DB (2006) Antiremodeling agents influence osteoblast activity differently in modeling and remodeling sites of canine rib. Calc Tissue Int 79:255–261CrossRef
83.
Tsuchimoto M, Azuma Y, Higuchi O, Sugimoto I, Hirata N, Kiyoki M, Yamamoto I (1994) Alendronate modulates osteogenesis of human osteoblastic cells in vitro. Jpn J Pharmacol 66:25–33PubMedCrossRef
84.
Russell RG (2007) Bisphosphonates: mode of action and pharmacology. Pediatrics 119(suppl 2):S150–S162PubMedCrossRef
Metadata
Title
Fourier Transform Infrared Imaging as a Tool to Chemically and Spatially Characterize Matrix-Mineral Deposition in Osteoblasts
Authors
Meghan E. Faillace
Roger J. Phipps
Lisa M. Miller
Publication date
01-01-2013
Publisher
Springer-Verlag
Published in
Calcified Tissue International / Issue 1/2013
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-012-9667-5

Other articles of this Issue 1/2013

Calcified Tissue International 1/2013 Go to the issue

Original Research

Assessing the Impact of Osteoporosis on the Burden of Hip Fractures

Original Research

No Reduction in Circulating Preosteoclasts 18 Months after Treatment with Zoledronate: Analysis from a Randomized Placebo Controlled Trial

Original Research

Increased Bone Mineral Density and Decreased Prevalence of Osteoporosis in Cervical Ossification of the Posterior Longitudinal Ligament: A Case–Control Study

Original Research

Effects of Strontium Ranelate Administration on Calcium Metabolism in Female Patients with Postmenopausal Osteoporosis and Primary Hyperparathyroidism

Original Research

Neurofibromatosis 1-Related Osteopenia Often Progresses to Osteoporosis in 12 Years

Original Research

Optimal Serum Concentration of 25-Hydroxyvitamin D for Bone Health in Older Korean Adults
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits